Redfund Capital (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) this morning announced its entry into a promissory note with Cannaki Beverage Inc., a Las Vegas, Nevada-based manufacturer of natural and organic functional beverages with core products that include still and carbonated beverages and Nano CBD infused flavored waters. According to the update, Redfund and Cannaki signed the two-year term convertible secured promissory note on March 27th 2019 for $1,000,000 at an annual interest rate of 14 percent. Redfund may convert the note at any time during the term, and the company has a right of first refusal to provide financing to Cannaki upon the same business terms offered to Cannaki by any other funders. Cannaki will afford Redfund stock warrants in its common stock equivalent to 20 percent of the note amount based upon its current valuation as of the effective date, stipulated to be $20,000,000. “Cannaki has a strong network in the USA, Mexico and Europe and they are planning to expand their products’ reach to Asia and South America,” Redfund Capital CEO Meris Kott stated in the news release. “We hope to help Cannaki align with a licensed Canadian producer and place their products on shelves in Canada when CBD beverages are permitted in Canada. Welcoming a beverage company with a strong experienced team to the portfolio is very exciting for Redfund and our beverage division. We believe branded products in the cannabis sector with a global rollout strategy will continue to emerge and lead the industry.”
To view the full press release, visit http://cnw.fm/61yKG
About Redfund Capital Corp.
Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related and healthcare-related companies. For further information, visit the company’s website at www.RedfundCapital.com.
NOTE TO INVESTORS: The latest news and updates relating to PNNRF are available in the company’s newsroom at http://cnw.fm/PNNRF
About HempWire
HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.
To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/
Do you have a questions or are you interested in working with HW? Ask our Editor
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…
WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…
Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…
Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call…
CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that…